Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BK CTLs for Refractory BK Infections in CAYA
NCT04197596Phase 2Recruiting
- Sponsor
- New York Medical College
- Start
- Jul 2020
- Primary completion
- Dec 2026
- Modality
- Allogeneic CAR-T, Tumor-Infiltrating Lymphocytes (TILs), TCR-Engineered T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of BK-virus specific CTLs in BK virus infection, sponsored by New York Medical College. Started Jul 2020; status: recruiting.
02
Drugs
BK-virus specific CTLs
03
Conditions
BK virus infection
Beyond the preview
Go deeper on NCT04197596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04197596.